ArticleJCI insight2023

Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.

Zhen Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.